| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 2022 | ELAN Elanco Animal Health Inc | Hoover R David50 | Director | Buy | 20,000 | $15.18 | $303,614.00 | +16.0% | -16.3% | -22.7% | |
| Sep 9, 2022 | ELAN Elanco Animal Health Inc | Simmons Jeffrey N52 | President, CEO And Director | Buy | 30,000 | $14.54 | $436,146.00 | New | -16.3% | -22.7% | |
| Sep 9, 2022 | ELAN Elanco Animal Health Inc | Herendeen Paul | Director | Buy | 10,000 | $15.03 | $150,250.00 | +136.9% | -16.3% | -22.7% | |
| Sep 9, 2022 | AMLX Amylyx Pharmaceuticals, Inc. | Viking Global Investors LP66 | 10% Owner | Sell | 1,400,000 | $29.80 | $41,719,639.31 | -2.7% | +24.0% | -31.3% | |
| Sep 8, 2022 | LNTH Lantheus Holdings, Inc. | Markison Brian A64 | Director | Sell | 41,812 | $84.24 | $3,522,292.53 | -21.9% | -35.7% | -21.4% | |
| Sep 6, 2022 | EGRX Eagle Pharmaceuticals, Inc. | Edlin Richard A. | Director | Sell | 6,800 | $30.99 | $210,732.00 | -23.1% | - | - | |
| Sep 6, 2022 | TLRY Tilray Brands, Inc. | Kennedy Brendan87 | Director | Sell | 350,000 | $3.22 | $1,128,015.00 | -4.8% | +47.6% | -6.0% | |
| Sep 6, 2022 | LQDA Liquidia Corp | Jeffs Roger66 | Chief Executive Officer | Buy | 43,820 | $5.57 | $243,989.76 | +37.8% | -7.8% | +21.9% | |
| Sep 6, 2022 | LNTH Lantheus Holdings, Inc. | Markison Brian A64 | Director | Sell | 1,693 | $78.50 | $132,900.50 | -3.3% | -29.5% | -16.0% | |
| Sep 6, 2022 | LQDA Liquidia Corp | Caligan Partners LP58 | Director, 10% Owner, See Remarks | Buy | 250,000 | $5.62 | $1,405,000.00 | +2.4% | -7.8% | +21.9% | |
| Sep 6, 2022 | LNTH Lantheus Holdings, Inc. | McHugh Julie53 | Director | Sell | 4,300 | $78.50 | $337,550.00 | -14.0% | -29.5% | -16.0% | |
| Sep 6, 2022 | VRNO Verano Holdings Corp. | Summerer Brett Andrew | Chief Financial Officer | Sell | 4,622 | $6.47 | $29,921.37 | -26.9% | - | - | |
| Sep 6, 2022 | VRNO Verano Holdings Corp. | Spreckman David | EVP, Marketing | Sell | 246 | $6.47 | $1,591.32 | -8.2% | - | - | |
| Sep 2, 2022 | UTHR United Therapeutics Corp | Sullivan Louis W62 | Director | Sell | 4,910 | $225.98 | $1,109,550.02 | -28.7% | +23.6% | +2.3% | |
| Sep 1, 2022 | TKNO Alpha Teknova, Inc. | Lowell Matthew50 | Chief Financial Officer | Buy | 10,000 | $4.61 | $46,096.00 | +100.0% | +6.8% | -58.6% | |
| Sep 1, 2022 | IRWD Ironwood Pharmaceuticals Inc | McCourt Thomas A66 | Chief Executive Officer | Sell | 26,446 | $10.65 | $281,649.90 | -3.5% | +11.8% | -14.5% | |
| Sep 1, 2022 | LLY Eli Lilly & Co | Zakrowski Donald A | Chief Accounting Officer | Sell | 1,000 | $301.00 | $301,000.00 | -15.9% | +20.4% | +80.7% | |
| Sep 1, 2022 | AMPH Amphastar Pharmaceuticals, Inc. | Petersen Floyd F.51 | Director | Sell | 500 | $29.44 | $14,721.50 | -0.6% | -0.7% | +83.6% | |
| Aug 31, 2022 | ESPR Esperion Therapeutics, Inc. | Warren Eric60 | Chief Commercial Officer | Buy | 1,000 | $7.46 | $7,460.00 | +1.9% | -12.3% | -78.6% | |
| Aug 31, 2022 | AKBA Akebia Therapeutics, Inc. | Burke Steven Keith61 | SVP, Chief Medical Officer | Sell | 1,147 | $0.36 | $415.79 | -0.3% | -31.4% | +281.6% | |
| Aug 31, 2022 | VRNO Verano Holdings Corp. | Weiss Darren Henry | COO, CLO, GC And Secretary | Sell | 56,517 | $6.52 | $368,694.30 | -9.0% | - | - | |
| Aug 31, 2022 | LQDA Liquidia Corp | Jeffs Roger66 | Chief Executive Officer | Buy | 993 | $4.90 | $4,870.17 | +0.9% | -16.1% | +19.1% | |
| Aug 31, 2022 | LQDA Liquidia Corp | Lippe Robert A54 | Chief Operations Officer | Buy | 1,918 | $4.90 | $9,406.83 | +2.0% | -16.1% | +19.1% | |
| Aug 31, 2022 | VRNO Verano Holdings Corp. | Summerer Brett Andrew | Chief Financial Officer | Sell | 1,292 | $6.52 | $8,428.49 | -17.5% | - | - | |
| Aug 31, 2022 | LQDA Liquidia Corp | Moomaw Scott | SVP, Commercial | Buy | 2,160 | $4.90 | $10,593.72 | +28.2% | -16.1% | +19.1% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.